文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

BH4增强内皮型一氧化氮合酶活性可减轻新生儿高氧诱导的内皮损伤并维护血管完整性

BH4-Mediated Enhancement of Endothelial Nitric Oxide Synthase Activity Reduces Hyperoxia-Induced Endothelial Damage and Preserves Vascular Integrity in the Neonate.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究采用内皮特异性eNOS-GFP过表达小鼠在出生后第7天暴露于高氧48小时,并用sepiapterin补充BH4,发现补充BH4可提升视网膜和脑BH4水平、增强NOS活性、减少硝基酪氨酸修饰蛋白,逆转eNOS过表达加重的血管退化;在原代视网膜微血管内皮细胞中,BH4补充恢复了高氧受损的增殖能力并改善血管覆盖。

要点

  • sepiapterin补充BH4可提升高氧暴露视网膜和脑的BH4水平并增强NOS活性。
  • BH4补充减少硝基酪氨酸修饰蛋白并逆转eNOS过表达加重的血管退化。
  • BH4补充恢复高氧下受损的视网膜微血管内皮细胞增殖及血管覆盖。

核心结论

  • 补充BH4可纠正高氧诱导的视网膜微血管内皮细胞功能障碍,并通过增强eNOS功能维护血管完整性。

研究设计与样本

  • 内皮特异性eNOS-GFP过表达小鼠在出生后第7天暴露于高氧48小时,设补充与不补充BH4组,BH4通过给予稳定前体sepiapterin实现。
  • 组织用于视网膜铺片凝集素染色测定血管覆盖,或用高效液相色谱测BH4、Western blotting测硝基酪氨酸、ELISA测VEGF、精氨酸-瓜氨酸转化测NOS活性。
  • 原代视网膜微血管内皮细胞接受类似处理并测定高氧诱导的损伤。

主要发现

  • sepiapterin有效提升高氧暴露视网膜和脑的BH4水平,升高NOS活性并减少硝基酪氨酸修饰蛋白。
  • BH4补充逆转了eNOS过表达时加重的血管退化。
  • 在原代视网膜微血管内皮细胞中,高氧介导的BH4耗竭通过降低亚硝酸盐和升高超氧化物使氧化还原平衡失调并损害增殖能力。
  • BH4补充在体外和体内均恢复原代视网膜微血管内皮细胞的正常增殖,与eNOS-GFP视网膜血管覆盖增加形成机制联系。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) has important vasoprotective functions that are compromised in the vasodegenerative phase of retinopathy of prematurity, owing to hyperoxia-induced depletion of the essential NOS cofactor BH4. Because modulating eNOS function can be beneficial or detrimental, our aim was to investigate the effect of BH4 supplementation on eNOS function and vascular regression in hyperoxia. METHODS: Endothelial-specific eNOS-green fluorescent protein (GFP) overexpressing mice at postnatal day 7 (P7) were exposed to hyperoxia for 48 hours in the presence or absence of supplemental BH4, achieved by administration of sepiapterin, a stable BH4 precursor. Tissue was collected either for retinal flat mounts that were stained with lectin to determine the extent of vessel coverage or for analysis of BH4 by high-performance liquid chromatography, nitrotyrosine (NT) marker by Western blotting, VEGF expression by ELISA, and NOS activity by arginine-to-citrulline conversion. Primary retinal microvascular endothelial cells (RMEC) were similarly treated, and hyperoxia-induced damage was determined. RESULTS: Sepiapterin effectively enhanced BH4 levels in hyperoxia-exposed retinas and brains, elevated NOS activity, and reduced NT-modified protein, leading to reversal of the exacerbated vasoregression observed in the presence of eNOS overexpression. In RMECs, hyperoxia-mediated depletion of BH4 dysregulated the redox balance by reducing nitrite and elevating superoxide and impaired proliferative ability. BH4 supplementation restored normal RMEC proliferation in vitro and also in vivo, providing a mechanistic link with the enhanced vascular coverage in eNOS-GFP retinas. CONCLUSIONS: These results demonstrate that BH4 supplementation corrects hyperoxia-induced RMEC dysfunction and preserves vascular integrity by enhancing eNOS function.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Edgar KS, Galvin OM, Collins A, et al. BH4-Mediated Enhancement of Endothelial Nitric Oxide Synthase Activity Reduces Hyperoxia-Induced Endothelial Damage and Preserves Vascular Integrity in the Neonate. Invest Ophthalmol Vis Sci. 2017. PMID: 28114584. doi:10.1167/iovs.16-20523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。